Advanced Search

Show simple item record

dc.contributor.authorBayram, Nurun Nisa
dc.contributor.authorIsoglu, Sevil Dincer
dc.contributor.authorBaran, Yael
dc.contributor.authorUlu, Gizem Tugce
dc.date.accessioned2022-02-16T11:32:17Z
dc.date.available2022-02-16T11:32:17Z
dc.date.issued2021en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps //doi.org/10.1016/j.annonc.2021.08.309
dc.identifier.urihttps://hdl.handle.net/20.500.12573/1150
dc.descriptionResearch grants from the Scientific and Technological Research Council of Turkey, "Development of Breast Cancer Targeted, More Stable, IV Double-Moiety pHSensitive, Drug-Conjugated, Multifunctional Micelle-Based Nanocarriers and Investigation of Their in vitro Efficiency", Project Number: 116R057.en_US
dc.description.abstractAdvantage of co-culture strategy for targeted cancer treatment and in vitro studiesen_US
dc.description.sponsorshipTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) 116R057en_US
dc.language.isoengen_US
dc.publisherELSEVIERRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDSen_US
dc.relation.isversionof10.1016/j.annonc.2021.08.309en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleAdvantage of co-culture strategy for targeted cancer treatment and in vitro studiesen_US
dc.typearticleen_US
dc.contributor.departmentAGÜ, Mühendislik Fakültesi, Malzeme Bilimi ve Nanoteknoloji Mühendisliği Bölümüen_US
dc.contributor.institutionauthorBayram, Nurun Nisa
dc.contributor.institutionauthorIsoglu, Sevil Dincer
dc.identifier.volumeVolume 32 Page S 370-S 370 Supplement 5 Meeting Abstract 31Pen_US
dc.relation.journalANNALS OF ONCOLOGYen_US
dc.relation.tubitak116R057
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record